우리나라 농촌인구의 기립 자세 흔들림과 치우침Postural Sway and Limb Load Asymmetry in the Rural Inhabitants in Korea
- Other Titles
- Postural Sway and Limb Load Asymmetry in the Rural Inhabitants in Korea
- Authors
- 신준호; 이규훈; 한승훈; 최보율; 박시복
- Issue Date
- Aug-2006
- Publisher
- 대한재활의학회
- Keywords
- Postural sway; Limb load asymmetry; Age; Bone mineral density; Diabetes
- Citation
- Annals of Rehabilitation Medicine, v.30, no.5, pp.502 - 507
- Indexed
- KCI
- Journal Title
- Annals of Rehabilitation Medicine
- Volume
- 30
- Number
- 5
- Start Page
- 502
- End Page
- 507
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181095
- ISSN
- 2234-0645
- Abstract
- Background/Aims: We performed a randomized, double-blind, phase III, multicenter trial to assess the comparative efficacy and safety of revaprazan, which is a novel acid pump antagonist in comparison with ranitidine for treating patients suffering with acute gastritis and acute aggravation of chronic gastritis. Methods: Five hundred and twelve subjects were randomized to 2 weeks of treatment with either revaprazan 200 mg q.d. or ranitidine 150 mg b.i.d. The primary efficacy parameter was the estimated improvement rate according to endoscopy, and the secondary efficacy parameter was the improvement rate for the subjects' symptoms. Results: The estimated improvement rates at 2 weeks (intention-to-treat analysis) were 79.9% with revaprazan and 60.5% with ranitidine; a significant difference was found between the two groups (p<0.0001). On the per-protocol analysis, the estimated improvement rates for revaprazan and ranitidine were 79.4% and 60.2%, respectively. There was a significant difference in the estimated improvement rates between the two groups (p<0.0001). On both analyses, there were no significant differences between the two groups for the improvement rates of the subjects' symptoms. Both drugs were well tolerated. Conclusions: The efficacy of revaprazan was higher than that of ranitidine for the estimated improvement rate according to endoscopy and also for the symptomatological improvement rate, and revaprazan was well tolerated by the subjects suffering with gastritis. (Korean J Gastrointest Endosc 2006;33:212-219)
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 예방의학교실 > 1. Journal Articles
- 서울 의과대학 > 서울 재활의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181095)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.